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Introduction. Stroke in people under 45 years of age is less frequent than in older populations but has a major impact on the
individual and society. In this article we provide an overview of the epidemiology and etiology of young stroke. Methods.T h i s
paper is based on a review of population-based studies on stroke incidence that have included subgroup analyses for patients
under 45 years of age, as well as smaller community-based studies and case-series speciﬁcally examining the incidence of stroke in
the young. Trends are discussed along with the relative frequencies of various etiologies. Discussion. Stroke in the young requires
ad i ﬀerent approach to investigation and management than stroke in the elderly given diﬀerences in the relative frequencies of
possible underlying causes. It remains the case, however, that atherosclerosis contributes to a large proportion of stroke in young
patients, thus, conventionalrisk factors must be targeted aggressively.
1.Introduction
Stroke incidence rises steeply with age; therefore, stroke in
younger people is less common; however, stroke in a young
person can be devastating in terms of productive years lost
and impact on a young person’s life. As will be outlined
below, some causes of stroke are more frequent in adults
under 45 years of age compared to more aged populations
[1]. We here provide an overview of the incidence and etiol-
ogy of young stroke.
While a speciﬁc deﬁnition of “young stroke” is lacking,
the vast majority of authors consider “young stroke” to per-
tain to individuals under 45 years of age. Hence, this paper
is based on a review of population-based studies on stroke
incidence that have included subgroup analyses for patients
under 45 years of age, as well as smaller community-based
studies and case-series speciﬁcally examining the incidence
and etiology of stroke in the young. Individual studies and
reviews were found by performing a medline search (1948-
present) using the search terms “young stroke,” “ischaemic
stroke and young,” “ischemic stroke and young,” “haemor-
rhagic stroke and young,” “hemorrhagic stroke and young,”
as well as “epidemiology and young stroke” and “etiology
and young stroke.” We also collected papers by examining
the references cited in these articles and selecting those
pertaining to the epidemiology of young stroke. Finally,
we examined prevalence in large population registries that
provided subgroup analyses for patients younger than 45
years of age. These were identiﬁed using the search terms
“epidemiology and stroke” and “population-based studies
and stroke.” Again, references were examined to identify
other stroke registries, which were examined with regard to
prevalence among young patients under age 45.
2.Incidence ofYoungStroke
Diﬀerences in methods of reporting the incidence of young
stroke make it diﬃcult to draw geographical comparisons.
While the majority of population-based studies report rates
for all stroke combined (ischaemic and haemorrhagic, in-
cluding subarachnoid haemorrhage), a few report rates for
ischaemic stroke alone. Furthermore, referral bias needs to
be considered when hospital-based registries as opposed to
community-based studies are used to examine the relative
proportion of young stroke, as is often the case in developing
countries. Moreover, incidence has been examined at dif-
ferent time points over several decades and incidence rates2 Stroke Research and Treatment
may change overtime. Finally, where authors have reported
incidence rates by age decile, it is apparent that even within
the“young stroke” category,incidenceincreases sharply with
age, particularly among the 34 to 44 year old age group [2–
12].
Despite these diﬃculties, some general trends are appar-
ent. Overall incidence rates under the age of 45 range from
7 to 15 in 100000 people/year for all stroke (ischaemic and
haemorrhagic) [13–17], with higher rates reported in some
countries [18]. A few studies reporting similar incidence
rates have examined all stroke in the 15 to 44 year old age
group [19, 20] or ischaemic stroke only in the 15 to 49
year old age group (6.6 to 11.4 in 100000 people/year)
[21–23]. Underthe age of35, ratesare less than 10 in 100000
people/year (ranging from 0 to 9) [3, 4, 9, 24]. Within the 35
to 44 year old age range, rates range from 22 to 45 in 100000
people/year [2–12]. There may be a greater incidence of
stroke in developing countries, such as Libya with a reported
rate of 47 in 100000 people/year for all stroke under the age
of 45 [18]. High rates have also been observed in Japanese
adults(70 in100000 inthe 35 to 44 year old age group)[25],
Hispanics (26 in 100000 in the 22 to 44 year old age group)
[26], and American blacks with a relative risk of 5 for all
stroke reported for blackscompared to whites (96 in 100000
versus 19 in 100000) within the 35 to 44 year old age group
in the Greater Cincinnati/Northern Kentucky Stroke Study
from1993-1994(anRRof2.2wasobservedinthe0to34year
oldagegroup)[24,27].This trend issupported bytheresults
of the Northern Manhattan Stroke Study demonstrating a
nonsigniﬁcant trend of increased risk among blacks aged
22 to 44 years old [26], as well as the Baltimore Washington
Co-op Young Stroke study [28, 29]. Interestingly, two studies
of Caribbean blacks demonstrate similar stroke rates to
those reported in other young stroke populations [9, 11],
suggesting that the increased risk among young blacks in the
United States might be related to socioeconomic variables,
although high rates are observed in South African blacks
of all ages [30, 31]. Very high young stroke rates were also
observed in a rural populationfrom Northern Portugal [32].
With regard to sex diﬀerences in the incidence of young
stroke, rates are greater among men than women in the 35 to
44 year old age group [2, 4, 10, 14]. Some population-based
studies demonstrate an increased incidence among women
under 30 years old [22, 33, 34], as do several case-series [34–
36].
3.EtiologyofYoungStroke
While a greater proportion of strokes are due to subarach-
noid haemorrhage and intracranial haemorrhage in young
adults (40–55%) compared to the general stroke population
(15–20%), [17, 26, 37], cerebral infarction is still most
common. An increased risk of cerebral infarction among
young adults with conventional vascular risk factors is
observed,particularlyindevelopingcountriesduetoincreas-
ing smoking rates and urbanization [38], as well as among
young blacks and Taiwanese patients with more adverse risk
factor proﬁles resulting in a greater relative contribution of
small vessel disease to young stroke [39, 40]. However, other
causes of stroke in young adults diﬀer in frequency from
those observed in the elderly [41]. This holds particularly
true in adults under 30 years of age.
In terms of etiology and relative strength of risk factors,
mostdatacomesfromclinicalseriesandcase-controlstudies.
The majority ofthese haveexamined adults lessthan 45years
of age, while the Helsinki Young Stroke registry examined
etiology in adults under 49 years of age [21]. In as many as
35% of cases, the underlying etiology remains unclear [21,
23, 29, 33, 34, 36, 42–44]. Importantly, while atherosclerosis
remains an important risk factor (accounting for 15–25% of
strokes in young adults [36], and an even greater proportion
among certain ethnicities) [40, 45], cardioembolic stroke is
more common among younger patients (15–35% of cases)
[21,29,33,34,36,42,43,45].Othercauses thatare more fre-
quent in young people include extracranial artery dissection
(2–25%ofcases)[21,29,36,40,42,46],migraine (upto20%
of cases [42], although thorough studies excluding alternate
possible causes suggest migraine contributes to just 1–5%
of cases [23, 29, 33–36]), and drug use (up to 5% of cases,
depending on the frequency of use in a given population
[29]). Oral contraceptive use has been implicated in up to
8% of cases of young stroke in some populations [43]. Apart
from antiphospholipid antibody syndrome (5–10% of cases)
[23, 29, 33, 34, 36, 42, 45], inherited coagulation disorders
do not appear to play a large role in young stroke in the
absence of right to left venoarterial shunting [47]. Sickle cell
disease, in which 7 to 10% of aﬀected individuals experience
s t r o k e sb e f o r et h ea g eo f2 0[ 48], and rheumatic valvular
heart disease are important in some populations, with as
many as 32% of cases of young ischaemic stroke attributable
to rheumatic heart disease in Iran [49]. Cerebral venous
thrombosis is an uncommon cause of young stroke (i.e.,
<1% of cases [50]), as are rare causes of nonatherosclerotic
arteriopathies (although they contribute to 15–35% of cases
of young stroke as a collective group [36]). These include
Sneddon’s syndrome; Moyamoya disease (responsible for 6–
15% of cases due to nonatherosclerotic arteriopathy (22–
27% of all young ischaemic stroke) in Asian populations
[40, 45]); mitochondrial myopathy, encephalopathy, lactic
acidosis, and stroke-like episodes (MELAS); cerebral auto-
somal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy(CADASIL);vasculitis; prior chemora-
diotherapy; HIV infection (up to 7% of cases of young
strokeinNigeria[51]);andneoplasm.Whileonlyspeciﬁcally
examined and demonstrated in young patients in South
Africa, in addition to sickle cell disease and rheumatic heart
disease, a higher prevalence of stroke secondary to vasculitis
due to infection likely occurs in developing countries [38].
With regard to stroke in women, oral contraceptive use
is associated with a 2- to 5-fold increased risk of stroke of
all subtypes, depending on the estrogen content, although
there is some controversy as to whether pills with a low
estrogen content (i.e., less than 50 micrograms of ethinyl
estradiol) are truly associated with an increased risk given
the discrepancy in results between cohort studies, which
do not support a link, and a large number of case-control
studies that do [52]. This risk is increased in smokers and inStroke Research and Treatment 3
thosewho experience migraine withaura[53].Less common
causes of stroke that are more common in women include
systemic lupus erythematosus (SLE), antiphospholipid anti-
body syndrome (APLAS),central venousthrombosis (CVT),
reversible cerebralvasoconstriction syndrome (RCVS),Susac
syndrome,Takayasu’sarteritis, Moyamoyadisease,Sneddon’s
syndrome, and ﬁbromuscular dysplasia. In addition, women
are particularly susceptible to stroke in the puerperium.
4.CardioembolicStroke
Diﬀerent frequencies of the various causes of cardioembolic
stroke are reported, and geographical variation is seen. The
methods and criteria that are used to identify potential
causes also vary. Mitral valve disease, which accounts for a
signiﬁcant proportion of cardioembolic stroke in young
patients, is more common in some populations due to a
high prevalence of rheumatic heart disease [49]. The relative
contribution of rheumatic heart disease (in the presence or
absence of synthetic valve prosthesis) and mitral valve pro-
lapse to cardioembolic stroke varies widely among diﬀerent
geographical regions and stroke registries from 40–70% in
most studies [33, 36, 40, 43, 49], and far less in the Helsinki
registry given the virtual disappearance of rheumatic fever
in Finland [21]. The prevalence of dilated cardiomyopathy
also demonstrates geographical variation in light of the
increased prevalence of Chagas disease in South America
(also associated with intramural thrombi) [54], as well as
the increased prevalence of alcohol abuse among certain
populations. Rates range from 4–17% [21, 36]. Reports
identify atrial ﬁbrillation in 2–20% of young patients who
have experienced a cardioembolic stroke [21, 33, 37, 38, 40,
47],morecommonlyinthesettingofrheumaticheart disease
[49], which is still less than that observed in older popula-
tions [43]. Other potential causes of cardioembolic stroke
include acute myocardial infarction and subacute bacterial
endocarditis. Rarely, aortic valve disease or left ventricular
thrombi are implicated. The relationship between presence
of a patent foramen ovale and ischaemic stroke is complex.
5.PatentForamenOvale (PFO) andStroke
The potential link between PFO and young stroke remains
a controversial subject. Somewhere in the area of twenty-
ﬁ v ep e r c e n to ft h ep o p u l a t i o nh a v eaP F O ,w h i c hi ni t s e l fi s
not associated with an increased incidence of ﬁrst everstroke
in large population studies [55], although a nonsigniﬁcant
trend toward an association has been observed, particularly
among individuals under the age of 60 with an atrial septal
aneurysm (ASA) [55–57]. PFO is, however, a more common
ﬁnding among young patients who present with cryptogenic
stroke [55].Ameta-analysis of nine case-control studies(566
patients and 459 nonstroke controls), the majority of which
examined patients under 55 yo, found that young patients
with cryptogenic stroke had an OR of 6.0 for having a PFO
compared to young patients with a known cause of stroke
(theORofhaving aPFOwas3.0forallyoungstrokepts)[55,
56]. The concurrent presence of an ASA, found in 2.2% of
the population[55], likely adds further risk [55, 57]. Reports
examining whether the presence of large septal defects might
conferadditionalriskhaveyieldedcontradictoryresults[55].
6.Thrombophiliainthe Settingof
PFOand Stroke
With the exception of APLAS, while thrombophilia on its
own is probably not associated with ischaemic stroke, there
issome evidencetosuggestthatthe prothrombingenemuta-
tion, in particular, might confer a greater risk of ischaemic
stroke in the setting of a PFO. As nongenetic laboratory
assays in the assessment of coagulopathies may be unreliable
in the acute phase of stroke [58], the most reliable studies
use genetic testing to identify patients with inherited throm-
bophilias.
In the largest case-control study examining this issue
(n = 125; mean age 34.7), an increased incidence of the pro-
thrombin gene mutation in particular (as well as more than
one thrombophilic defect) was found among young stroke
patients with a PFO compared to those with infarction unre-
lated to presence of a PFO [47]. The results of three smaller
case-control studies are inconsistent [59–61]. The role of
FV61691A and TT MTHFR mutations is even less clear with
weak or no demonstrated link observed in the absence of
more than one defect [47, 59]. Two retrospective reviews of
recurrent stroke in patients referred for PFO closure have
demonstrated a greater incidence of recurrent stroke among
those with thrombophilia; however, the thrombophilic
groups have included patients with APLAS (for which there
is a known association with stroke) and evidence of throm-
bophilia on biochemical testing alone, making it diﬃcult to
tease out the relative contribution of genetically-determined
inherited thrombophilias to the observed increased risk [62,
63].
7.Migraine and Stroke
The weight of evidence from case-control studies suggests
that migraine, particularly migraine with aura, is associated
with an increased risk of ischaemic stroke in young women
under 45 years of age [53, 64–69]. The pathophysiological
mechanism underlying this remains unclear. For one, it is
diﬃc u l tt ot e a s eo u tt h er e l a t i v ec o n t r i b u t i o no fc a s e si n
which migraine precedes ischaemia (i.e., in which stroke
occurs secondary to cerebral hypoperfusion during the
aura phase), comprising a migrainous infarct, from cases
in which migraine with aura is experienced secondary to
ischaemia. True migrainous infarcts are probably rare and
tend to aﬀect the posterior circulation [53]. It is also
possible that young patients with a history of migraine
have an increased incidence of stroke due to a shared
underlying etiology which predisposes to both. Migraine
as a risk factor for future ischaemic stroke seems to apply
mostly to young women, and the relative risk may be as
high as 3-fold in those who experience migraine with aura
[53]. Several associations which might predispose to stroke
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of case-control studies, including carotid artery dissection
[70, 71] and the presence of a patent foramen ovale [72–75];
however, this does not explain the observed sex diﬀerence in
the frequency of ischaemic stroke among migraineurs [53].
What is known is that there is an additive risk of stroke
in women who experience migraine with aura that smoke,
with a greater than 3-fold increase in risk, as well as in those
who use the oral contraceptive pill, in whom the risk is
quadrupled [53]. An OR of 34 to 35 has been reported for
young women who smoke, use the oral contraceptive pill,
and experience migraine with aura [53].
8.StrokeinthePuerperium
Strokecomplicatesanestimated34in100000deliveries[76],
although reported incidence rates vary from 4 to 210 in
100000 deliveries (RR = 3) [77–80], contributing to at least
12% of maternal deaths [81–83]. Some reports suggest that
ischaemic and haemorrhagic stroke occur in roughly equal
proportions[81,84,85],althoughischaemicstrokewasmore
common in one study [86]. Treadwell et al. propose that this
may be due to diﬀerences in patient subgroup selection since
some studies exclude stroke secondary to cerebral venous
thrombosis, which contributes to a signiﬁcant proportion
of ischaemic strokes in the puerperium (38% in one series
[86],althoughlowerandhigherrateshavebeenreported[87,
88]). Nonetheless, arterial occlusion remains most common
[86, 88]. Most strokes occur peri- or postpartum [86, 89]
with a relative risk of 8.7 for ischaemia in the ﬁrst six weeks
postpartum [82, 85], during which cerebral vein thrombosis
is also more common [81, 89, 90], and a relative risk of 5.6
for intracerebral haemorrhage during pregnancy [81, 91].
Looking at intracerebral and subarachnoid haemorrhage
combined, a 2.5-fold increasedr i s ko fh a e m o r r h a g i cs t r o k e
has been reported in pregnancy, and a 23.8-fold increased
riskpostpartum[81,91].Halfofcasesofaneurysmal rupture
in women under the age of 40 occur in pregnancy [81, 92].
Causes of stroke in pregnancy include haemorrhagic and
ischaemic stroke in the setting of pre-eclampsia and eclamp-
sia (25–45% of patients with pregnancy-related stroke)
[81, 85, 91], arterial dissection, peripartum cardiomyopathy,
paradoxical embolism, amniotic ﬂuid embolism, postpar-
tum cerebral angiopathy, and cerebral vein thrombosis.
Cerebral haemorrhage is the most common cause of death
in patients with eclampsia but associations between pre-
eclampsia and eclampsia and ischaemic stroke are also
observed [76, 85, 93]. Subarachnoid haemorrhage is the
third leading cause of nonobstetric-related maternal death
[77, 81], often secondary to aneurysmal rupture [85, 91].
Whether or not the presence of a patent foramen ovale
alone is associated with an increased stroke risk in pregnancy
has not been properly examined, nor has the incidence
of pregnancy-related stroke in association with peripar-
tum cardiomyopathy. Post-partum angiopathy, a reversible
cerebral vasoconstriction syndrome usually occurring in
the ﬁrst week postpartum, may be more common than
initially thought, although the exact incidence is unknown.
It may or may not be associated with pre-eclampsia or
eclampsia and cases have also been seen in association with
vasospastic drugs, such as ergonovine and bromocriptine
during pregnancy [78, 79, 81].
9.AntiphospholipidAntibodySyndrome
Ischaemic strokewas the most common presentation of arte-
rial thrombosis in 1000 patients (mean age 42 ± 14 years)
fulﬁlling the Sapporo criteria [80, 94] for antiphospholipid
syndrome (stroke was the incident event in 13% of patients
and TIA in 7%) in a large cohort study [95]. There is little
doubt that such patients are at increased risk. However,
although case-control studies have uniformly demonstrated
a higher prevalence of antiphospholipid antibodies among
young people who have experienced ischaemic stroke [96–
100], studies documenting the persistence of antiphospho-
lipid antibodies following ischaemic stroke in the young are
lacking. Ischaemia may transiently induce antiphospholipid
antibodies, and prospective studies examining the stroke
incidence among patients found to have antiphospholipid
antibodies in the absence of an incident event have not been
performed [101]. Whether or not the presence of lupus anti-
coagulant poses a greater risk than other antiphospholipid
antibodies remains unclear. Consistent associations between
young ischaemic stroke and the presence of lupus anticoag-
ulant and anticardiolipin antibodies are seen [96–100, 102,
103],althoughthereare conﬂictingreportsregarding thesig-
niﬁcance of anticardiolipin antibodies in older stroke popu-
lations [104–106]. Interpretation is complicated by method-
ological diﬀerences and the use of diﬀerent cut-oﬀ values
with stronger associations observed at higher titre cutoﬀs.
With regard to the increased incidence of young stroke
among patients with systemic lupus erythematous found to
have antiphospholipid antibodies, lupus alone is associated
with an increased incidence of cerebrovascular events, which
can be mediated by targeting conventional risk factors. As
such, it is diﬃc u l tt ot e a s eo u tt h er e l a t i v ec o n t r i b u t i o no f
antiphospholipid antibodies in these patients.
10.NonatheroscleroticVasculopathies
Cervicalartery dissection,migraine, vasculitis,includingpri-
mary cerebral angiitis, infection (including HIV), radi-
ation vasculopathy, cerebral autosomal dominant arteri-
opathy with subcortical infarcts and leukoencephalopathy
(CADASIL), mitochondrial myopathy, encephalopathy, lac-
tic acidosis and stroke-like episodes (MELAS), reversible
cerebral vasoconstriction syndrome (RCVS), Moyamoya,
Sneddon’s syndrome, Fabry’s disease, and malignancy, all
come under the heading of nonatherosclerotic arteri-
opathies. The most common of these in young stroke pa-
tients is cervical artery dissection (CAD), which has been
implicated in up to 20–25% of cases of young stroke [21,
23, 42], followed by vasculitis related to infection (up to
7% of cases depending on the geographical region [51]),
Moyamoya in Asian populations (6–15% of cases of nonath-
erosclerotic vasculopathy [40, 45]), and migraine (probably
closest to 1–5% of cases [21, 23, 29, 33–36]). While, asStroke Research and Treatment 5
a collective group, the remaining nonatherosclerotic vascu-
lopathies contribute to 7–25% of cases of young stroke along
with CAD, migraine, infection, and Moyamoya [36, 40, 43,
45], each is responsible for less than 1% of cases. Many of
the nonatherosclerotic vasculopathies demonstrate ethnic,
geographical, and genetic links making them more common
in some populations than others. Similar to Moyamoya,
Takayasu’s arteritis is more common in Asian females for
example (approximately 1% of cases of nonatherosclerotic
arteriopathy in Korea) [45]. Vasculitis related to infection
as a cause of young stroke is more common in developing
countries and in geographical regions with a high prevalence
of HIV [51]. Primary cerebral angiitis, a rare cause of stroke,
is more common in middle-aged men [107], and MELAS
is a maternally inherited mitochondrial disorder. Reversible
cerebralvasoconstriction syndrome,whichmaybeunderrec-
ognized, is more common in females [108], as is Sneddon’s
syndrome [109], while both familial and sporadic cases of
CADASIL have been described [110, 111].
It should be noted that, apart from primary cerebral
angiitis, systemic vasculitides rarely involve the intracranial
vessels to produce stroke. Rather, concurrent atherosclerotic
disease (and rarely nonbacterial thrombotic endocarditis) is
a much more important cause of stroke in patients with
systemic lupus erythematosus, for example.
11.ExtracranialArterialDissection
Cervical artery dissection (CAD)accounts for up to one ﬁfth
of ischaemic strokes in young and middle-aged patients [23,
112, 113].In amajority ofcases, thespeciﬁc etiologyremains
unknown. Trauma, infection, migraine, ﬁbromuscular dys-
plasia, and a range other causes have been linked with CAD
but evidence to support strong links is limited [112, 114].
With regard to CAD epidemiological observations sug-
gest that some as-yet unrecognized predisposing factors
couldbe heritable[112,115–117].Arecentmeta-analysishas
observed a probable link with Ehlers-Danlos but no other
consistent associations, although there is little doubt that
genetic factors play a role given the high proportion of con-
nective tissue defects noted on specimens and the observed
clustering of CAD in families [112]. Environmental triggers,
such as infection, are likely also important [112].
12.HaemorrhagicStroke
The largest studies indicate that subarachnoid and intracra-
nial haemorrhage comprise 25–55% of all strokes under the
age of 45 [17, 26, 118, 119] with reported incidence rates
ranging from 3 to 6 in 100000 people/year for subarachnoid
haemorrhage, and 2 to 7 in 1000000 people/year for intra-
cranial haemorrhage under the age of 45 [18, 20, 26, 120]
(the greatest reported incidence rates are for adults aged 20
to 44 in the Northern Manhattan Stroke Study, while other
studies have examined adults from age 15 to 44).
The known association between hypertension and in-
tracranial haemorrhage may explain the increased rate of
intracranial haemorrhage observed among young blacks in
America [26, 39], with one study speciﬁcally demonstrating
an increased incidence of hypertensive intracranial haemor-
rhage among young blacks [39]. A relatively high proportion
of intracranial haemorrhage has also been noted in young
Nigerians, althoughtheanalysis was hinderedbytheinability
of many patients to aﬀord a CT scan [51]. An increased risk
of intracerebral haemorrhage has also been observed in His-
panics in the Northern Manhattan Stroke Study [26]. This
issue has not been well examined among young Asians, apart
from a study in North India that did not ﬁnd an increased
proportion of haemorrhagic to total strokes (i.e., only 14%
of cases were haemorrhagic) [121]c o m p a r e dt oW e s t e r n
countries(withreported proportionsintherange of40–55%
ofallyoungstrokes[17,26,119]).Arelativelylowproportion
of haemorrhagic stroke has also been observed in Saudia
Arabia (13% of cases) [122]. Larger scale population studies
are required to explore this further. Vascular malformations
(aneurysms and arteriovenous malformations) were found
in 49% of patients in a retrospective evaluation of 200 cases
of intracranial haemorrhage in a tertiary medical centre in
Mexico [123]. A high proportion of haemorrhagic stroke
secondary to vascular malformations has also been reported
in developing countries, although formal angiography is
less accessible and reported frequencies are somewhat lower
[121].
Animportant considerationin young persons presenting
with intracerebral haemorrhage is the possibility of illicit
drug use. In a large American population-based study exam-
ining drug use among young patients hospitalized with
haemorrhagic (n = 937) or ischaemic (n = 998) stroke,
increased young haemorrhagic stroke rates were observed
in association with increased rates of amphetamine and
cocaine abuse over a period of three years. An odds ratio
of 5 (95% CI 3.24–7.55) for young haemorrhagic stroke in
the setting of amphetamine abuse, and 2.33 (95% CI 1.74–
3.11) in the setting of cocaine abuse was observed. Cocaine
abuse was also associated with an increased rate of ischaemic
stroke (OR 2.03; 95% CI 1.48–2.79) [124]. There is now a
convincing body of evidence to suggest a high prevalence
of underlying cerebrovascular abnormalities among patients
experiencing ICH or SAH in association with cocaine and
other drug abuse [125].
13.Conclusion
In summary, stroke in the young requires a diﬀerent ap-
proach to investigation and management than stroke in the
elderlygivendiﬀerencesintherelativefrequenciesofpossible
underlying causes. Haemorrhagic stroke is common, and
vascular imaging is recommended given a high frequency of
underlyingvascularanomalies. Itisalsoimportant toexplore
the possibility of illicit drug use in these cases. With regard
to ischaemic stroke, the increased frequency of dissection
mandates a high index of suspicion for imaging the extracra-
nial and intracranial vessels. Whilst the commonest cause of
cardioembolic stroke in the elderly is atrial ﬁbrillation, in
a young patient transoesophageal echocardiography looking
for the presence of a patent foramen ovale ± an atrial septal6 Stroke Research and Treatment
aneurysm will have a higher yield. One must not forget,
however, that atherosclerosis still contributes to a large
proportion of stroke in young patients and likely explains at
least some of the ethnic diﬀerences noted in the incidence
of stroke, emphasizing the need for aggressive risk factor
management. This, as well as diﬀerences in the prevalence
of other causative etiologies, such as rheumatic fever and
infection, combined with a younger background population
age distribution, may contribute to an increased incidence of
young stroke in developing countries. Finally, the incidence
of stroke appears greater in women than men under the age
of 30, and women are at increased risk of haemorrhage and
infarction in the puerperium. Additional history, including
use of the oral contraceptive pill, and testing for antiphos-
pholipid antibodies is important in young women.
There is a need for further research in young stroke,
particularly population-based studies utilising standardised
methodology.These will provideclarity byenabling compar-
ison of incidence rates between countries and trends over-
time, and insights into underlying etiological mechanisms.
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